By acting on areas of the brain that control hunger, semaglutide helps people feel full sooner and reduces cravings for food
help manage blood sugar levels in adults with type 2 diabetes, along with diet and exercise reduce the risk of cardiovascular problems such as heart attack in adults with type 2 diabetes and cardiovascular disease (CVD) Ozempic is also FDA approved to: reduce the risk of worsening kidney disease and serious heart-related problems in adults with type 2 diabetes and chronic (long-term) kidney disease, which in turn helps lower the risk of decreased kidney function and death due to cardiovascular events such as stroke Trulicity is also FDA approved to: reduce the risk of cardiovascular problems in adults with type 2 diabetes and multiple risk factors for CVD, such as smoking, high cholesterol, high blood pressure, or obesity Neither drug is approved to treat type 1 diabetes
In-vitro studies show it can enhance epidermal regeneration, boost synthesis of collagen types I, III, and IV, and improved markers of skin differentiation
Nausea: This is the most common complaint, especially when starting the medication or increasing the dose